Opinions on Teva Pharmaceutical Industries Limited (NASDAQGS:TEVA)
| Change: | -0.36 (-0.75%) |
| Last Trade: | 47.56 |
| Market Cap: | 38.91B |
| Price/earning ratio: | 22.40 |
| Share Volume: | 7,196,700 |
| Dividend yield: | 1.10% |
| Short % of float: | N/A |
| Beta: | 0.58 |
| Today | 5d | 1m | 3m | 6m | 1y | 5y |
Top 2%
May 18 at 3:03 ET
Genentech has shown great great returns over the past 5 years Return on Equity nearly 20% and return on capital over 15%. over the past 10 years sales are up 25%/year One of their major products Avastin has been approved in the treament of various canc...
Top 1%
May 15 at 12:16 ET
About generic drugs and the cost of maing them..
Teva is an Israeli pharmaceutical manufacture. This space is very interesting but with salaries being paid in Israeli currency TEVA is seeing it's costs rising while most of it's revenue is in USD.. the question is, how much of TEVA's business module can ...
Top 1%
TEVA Opinions
- Post a new opinion
- Recently posted
- Private notes
- Portfolio & watchlist
- Subscribed
- My Opinions
Sort By Date | Rank